| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 43K | $2.94M | $68.48 | Nov 10, 2025 | Direct |
| Editas Medicine, Inc. | Director | Stock Option (right to buy) | 37.5K | Jun 6, 2025 | Direct | ||
| HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 5.75K | May 1, 2025 | Direct | ||
| Syneos Health, Inc. | Director | Class A Common Stock | 0 | $43.00 | Sep 28, 2023 | Direct |